As previously reported, the downregulation of RUNX2 by ActRIIA during the early stages of CKD contributes to the development of osteoporosis components of MBD and cardiovascular diseases (Williams et al. 2018). This evidence concerns the gene ACVR2A and Marchiafava-Bignami disease.